China Biopharmaceuticals Holdings, Inc. (OTC BB: CHBP) ("China Biopharmaceuticals" or the "Company"), a China-based advanced and vertically integrated biopharmaceutical company focused on developing, commercializing, manufacturing and distributing innovative drugs, today announced that it has closed on a $6-million equity financing with $900,000 over allotment. Details will be presented in a Form 8K, which the Company will file as soon as practicable.
